Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.
about
Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-AnalysisDouble immunofluorescence labelling of routinely processed paraffin sections.An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2.Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.Overexpression of MACC1 and the association with hepatocyte growth factor/c-Met in epithelial ovarian cancer.A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growthMET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction.Role of endocrine and growth factors on the ovarian surface epithelium.HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancerINC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell modelsc-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications.Early preinvasive lesions in ovarian cancer.Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.A comparative quantitative analysis of laminin-5 in the basement membrane of normal, hyperplastic, and malignant oral mucosa by confocal immunofluorescence imaging.C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer.Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer.Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas.HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
P2860
Q26749186-EBBF8998-0803-4542-8A1A-FFB656681590Q30890923-6F5FBD61-9C75-48F5-9D62-C8F10E888B66Q33588267-1A21499D-3EC1-4D73-88AB-032EADF33FC0Q33622575-1BD2882D-84D9-49DF-9B99-4EEAADBE9F17Q33645224-FD082E2A-C733-43C9-AD1A-B4E6948EB410Q33785102-7A5B3DEC-59B7-40C3-ACE3-3DF94B8DF460Q35203637-DFF87632-920E-4B0C-A06F-3D1656920604Q35742089-BCA70568-C9F1-4163-8CCC-D2E4A3A9553EQ35747034-8A4ADDD0-8E30-4F83-8283-91BE4A9C49BAQ35952832-3F06673F-A1FF-43E4-B67F-25B13B13A7D3Q36520263-8800B029-83FE-4BDB-B19A-79CDBC20BA4CQ36703049-77D0216B-D7D2-4916-B497-B459DA3159A4Q37104714-A470FEAB-6832-425D-B765-65FEB9BAF92EQ37502372-73976608-FABE-4E75-A8EC-57700DC4F3CDQ37651008-E186062E-2C26-41D4-9A2F-B562B5AC2A3CQ37719090-C1F5974B-6EF3-4B8E-AD63-A8A5EC2AD8F4Q38314637-D410C04A-A225-45DD-9BDD-6CD19870A3A2Q38824065-42608C29-A325-4FDD-B79B-A12DCE7715EDQ39836976-22F63FEE-BDC8-4BCA-B261-3544C06BB710Q42510257-E766F0BF-479F-43F3-95B2-95374C36737DQ45083973-6D558DC4-1442-4A15-A116-46125D39FF5BQ47616848-0DFE3E24-C64F-48C4-BEA7-62D563285814Q51335207-A0629B61-9CD5-409E-811F-30D003C466B0Q53280611-E694144C-CD54-4FE1-8649-EDAD3FA6789DQ54245240-41D7393E-A0A1-46E7-9E03-AD580C539E2CQ54976417-E6CA5E3F-F0A5-42F2-BE6E-C88048D11537
P2860
Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Comparison of c-met expression ...... itative laser scan microscopy.
@ast
Comparison of c-met expression ...... itative laser scan microscopy.
@en
type
label
Comparison of c-met expression ...... itative laser scan microscopy.
@ast
Comparison of c-met expression ...... itative laser scan microscopy.
@en
prefLabel
Comparison of c-met expression ...... itative laser scan microscopy.
@ast
Comparison of c-met expression ...... itative laser scan microscopy.
@en
P2093
P2860
P1476
Comparison of c-met expression ...... itative laser scan microscopy.
@en
P2093
D Huntsman
E Klineberg
N Auersperg
P2860
P304
P356
10.1016/S0002-9440(10)65130-9
P407
P577
1999-08-01T00:00:00Z